Direct inhibition of CDK9 blocks HIV-1 replication without preventing T-cell activation in primary human peripheral blood lymphocytes
Open Access
- 19 September 2007
- Vol. 405 (1-2) , 65-78
- https://doi.org/10.1016/j.gene.2007.09.010
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional programGenes & Development, 2006
- Mechanisms controlling CDK9 activityFrontiers in Bioscience-Landmark, 2006
- Flavopiridol, An Inhibitor of Transcription: Implications, Problems and SolutionsCell Cycle, 2004
- Overview of interleukin-2 function, production and clinical applicationsCytokine, 2004
- T Cell Receptor Signaling: Beyond Complex ComplexesJournal of Biological Chemistry, 2004
- CDK9 Is Constitutively Expressed throughout the Cell Cycle, and Its Steady-State Expression Is Independent of SKP2Molecular and Cellular Biology, 2003
- Flavopiridol Inhibits P-TEFb and Blocks HIV-1 ReplicationJournal of Biological Chemistry, 2000
- In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral VectorScience, 1996
- Interleukin 2 regulates the expression of Tac antigen on peripheral blood T lymphocytes.The Journal of Experimental Medicine, 1984
- Interleukin 2 Regulates Expression of Its Receptor and Synthesis of Gamma Interferon by Human T LymphocytesScience, 1984